Academic detailing

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Academic detailing is “university or non-commercial-based educational outreach.”[1] The process involves face-to-face education of prescribers by trained health care professionals, typically pharmacists, physicians, or nurses. The goal of academic detailing is to improve prescribing of targeted drugs to be consistent with medical evidence from randomized controlled trials, which ultimately improves patient care and can reduce health care costs. A key component of non-commercial or university-based academic detailing programs is that they (academic detailers/clinical educators, management, staff, program developers, etc.) do not have any financial links to the pharmaceutical industry.

Academic detailing has been studied for over 25 years[2] and has been shown to be effective at improving prescribing of targeted medications about 5% from baseline.[3] Though it is primarily used to affect prescribing, it is also used to educate providers regarding other non-drug interventions, such as screening guidelines.

Organizations[edit]

Many academic detailing programs exist around the world. In the United States, university-based state programs exist in Vermont,[4] Oregon[5] and South Carolina.[6] The nonprofit organization Alosa Health runs an academic detailing program in Pennsylvania, Massachusetts and Washington, DC called the Independent Drug Information Service (IDIS). The National Resource Center for Academic Detailing (NaRCAD), funded by the Agency for Healthcare Research and Quality (AHRQ) in 2010 was created to help organizations with limited resources to establish and improve their own programs and to create a network of academic detailing programs. Programs also exist in Canada through the Canadian Academic Detailing Collaboration (CADC)[7] and Australia through the Drug and Therapeutics Information Service (DATIS) and the National Prescribing Service (NPS). In Belgium academic detailing is provided by Project Farmaka.

See also[edit]

Silva, JM; Stein, AT; Schünemann, HJ; Bordin, R; Kuchenbecker, R; de Lourdes Drachler, M (19 March 2013). "Academic detailing and adherence to guidelines for Group B streptococci prenatal screening: a randomized controlled trial.". BMC pregnancy and childbirth. 13: 68. PMC 3610286Freely accessible. PMID 23510061. doi:10.1186/1471-2393-13-68. 

References[edit]

  1. ^ Soumerai SB, Avorn J (1990). "Principles of educational outreach ('academic detailing') to improve clinical decision making". JAMA. 263 (4): 549–56. doi:10.1001/jama.1990.03440040088034. 
  2. ^ Avorn J, Soumerai SB (1983). "Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing". N Engl J Med. 308 (24): 1457–63. doi:10.1056/nejm198306163082406. 
  3. ^ O'Brien MA, Rogers S, Jamtvedt G, et al. (2007). "Educational outreach visits: effects on professional practice and health care outcomes". Cochrane Database Syst Rev. 4: CD000409. doi:10.1002/14651858.cd000409.pub2. 
  4. ^ http://www.med.uvm.edu/ahec/TB1+BL.asp?SiteAreaID=290
  5. ^ https://web.archive.org/web/20110720024858/http://pharmacy.oregonstate.edu/drug_policy/index.php?nav=ROAD
  6. ^ http://www.sccp.sc.edu/SCORxE
  7. ^ http://ebm.oscarmcmaster.org/ebm-resources/CADC%20Handout%202008.doc